The Bioentrepreneur Roundtable brings together biotechnology executives with a wealth of experience in financing and running start-ups.
The next Roundtable will be held on 7 March 2006 at 18:30 at the Hôtel InterContinental Genève in Geneva, Switzerland and will concentrate on investor exit strategies for small biotech companies in Europe.
Chaired by Sabine Louët, News Editor at Nature Biotechnology, the Roundtable panelists include: Niels Ackermann of Wilex; Peter Buckel of SuppreMol (formerly Atugen); Ulrich Dauer of 4SC; Patrick Frei of Venture Valuation and Jean-Yves Nothias of SGAM.
The Bioentrepreneur Roundtable, held prior to the start of the BioSquare 2006 conference, promises to attract executives from small- to medium-sized biotech companies as well as interested Nature Biotechnology readers.
The next Bioentrepreneur Roundtable will be announced shortly.
For more information please contact:
Sabine Louët : [email protected]
Nature Biotechnology is a leading monthly peer-reviewed journal covering the science and business of biotechnology. Published by the Nature Publishing Group, it focuses on new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covering the commercial, political, ethical, legal, and societal aspects of this research.